Healthcare

ResMed Inc (ASX:RMD), a global developer of cloud-connected medical devices and digital health solutions for sleep apnea and other chronic respiratory conditions, has declared a quarterly unfranked dividend of USD 0.06 per Chess Depositary Instrument (CDI) for holders listed on the Australian Securities Exchange …

PolyNovo Limited (ASX:PNV)has received an endorsement fromMacquarie Research, which reaffirmed its“Outperform” ratingon the stock, assigning a target price ofAUD 2.45— an ambitious100% upsidefrom its current trading level of AUD 1.23 per share (as at July 30, 2025).

Regis Healthcare Limited (ASX:REG) has announced a binding agreement to acquire Rockpool RAC Holdings Pty Ltd, a Queensland-based aged care provider, in a transaction that will expand Regis’ presence in the premium aged care sector. The acquisition includes four recently developed residential aged care …

Mesoblast Limited (Nasdaq: MESO; ASX: MSB), an Australian-headquartered company developing allogeneic cellular medicines for inflammatory diseases, has reported unaudited gross revenue of AUD 13.2 million from sales of its FDA-approved product Ryoncil® (remestemcel-L-rknd) in the United States for the quarter ended 30 June 2025. …

IMC share price increased 16.9% to 7.6 cents per share on 17 July 2025.

Noxopharm Limited (ASX:NOX), a clinical-stage biotechnology company, has initiated dosing in its first-in-human HERACLES clinical trial, marking the initial human application of SOF-SKN™, a topical drug candidate designed to address autoimmune diseases. The trial represents the first clinical step for the company’s proprietary Sofra™ …

Lumos Diagnostics (ASX:LDX) soared 155% to 7.4 cents per share in morning trading on 16 July 2025, after the company announced a landmark U.S. distribution and supply agreement for its flagship diagnostic product FebriDx®. The agreement, signed with PHASE Scientific International Limited, is valued …